GE HealthCare Technologies recently expanded its PETtrace Solid Target Platform to support Copper-64 production and secured ...

GE HealthCare Technologies (GEHC) has put molecular imaging in focus after securing CE Mark approval for its MINItrace Magni ...

GE HealthCare claimed European approval for a compact cyclotron designed for the local production of rapidly decaying PET ...

MINItrace Magni is an automated, self-shielded cyclotron developed for in-house radioisotope manufacturing.

GE HealthCare secures CE Mark for MINItrace Magni cyclotron, enabling on-site fluorine-18 production for PET scans and ...

A Florida State University–led review shows how ultrahigh-resolution mass spectrometry can help researchers identify the ...

A systematic review of all 54 African nations finds radionuclide cancer therapies available in only a fraction of countries, ...

Over the past three years, Malta Enterprise issued almost €500,000 in direct orders on works related to a machine that has lain dormant for years and has been immobilised by a court freezing order ...

A survey of South African academic hospitals shows heavy patient demand but severe radiopharmacist shortages, offering a data-driven blueprint for planning nuclear medicine and radiopharmacy services ...

GE HealthCare agreed to acquire SOFIE Biosciences for $945 million, targeting SOFIE's 21-cyclotron US manufacturing network.

The compelling prospect is an overconstrained answer: enough independent information that neutrino mass can no longer move ...

The Nationalist Party has called on the Government to provide a full account of the expenditure on the Cyclotron, a machine ...